RELVAR® 100 ELLIPTA® Special Drug Use Investigation (COPD, Long-term)

Clinical trial NCT03219255 · COMPLETED

Trial details

NCT number: NCT03219255
Sponsor: GlaxoSmithKline
Status: COMPLETED
Study type: OBSERVATIONAL

Pulmonary Disease, Chronic Obstructive

Start date: 2017-08-30
Primary completion: 2021-03-30
Enrollment: 1047

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.